Skip to content

Clinical trials

Observational Cardiomyopathies trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Observational Country / region: Japan Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20181
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals1
Bristol-Myers Squibb1
Hiroaki Shimokawa, MD, PhD1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies4
Amyloidosis1
Arrhythmias, Cardiac1
Cardiac Conduction System Disease1
Cardiomyopathy, Hypertrophic1
Coronary Disease1
Death, Sudden, Cardiac1
Heart Failure1
Heart Valve Diseases1
Hypertrophy, Left Ventricular1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.